Provocation--the best way to start warfarin treatment
Schnell, R.
Lakartidningen 105(34): 2262-2263
2008
ISSN/ISBN: 0023-7205 PMID: 18785600 Document Number: 623884
Document emailed within 1 workday
Related Documents
Odén, A.; Fahlén, M. 2008: Provocation at the initiation of warfarin treatment Lakartidningen 105(37): 2500Scott, E.A.; Sandler, G.A.; Byars, T.D. 1978: Warfarin: effects of intravenous loading doses and vitamin K on warfarin anticoagulation in the pony American Journal of Veterinary Research 39(12): 1888-1891
Koefoed, B.G.; Feddersen, C.; Gulløv, A.L.; Petersen, P. 1997: Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation Thrombosis and Haemostasis 77(5): 845-848
First, M.R.; Goldberg, B.; Abrahams, C. 1972: Dipyridamole (persantin) and warfarin in the treatment of glomerulonephritis South African Medical Journal 46(25): 848-849
Egermayer, P.; Inder, A.; Town, G.I. 2001: The use of warfarin in Christchurch for the treatment of venous thromboembolism New Zealand Medical Journal 114(1136): 336-338
Berman, P.A.; Gwatkin, D.R.; Burger, S.E. 1987: Community-based health workers: head start or false start towards health for all? Social Science and Medicine 25(5): 443-459
Berman, P.A.; Gwatkin, D.R.; Burger, S.E. 1987: Community-based health workers: head start or false start towards health for all? Social Science and Medicine 25(5): 443-459
Anderson, J.N.; Shaw, S. 2001: What is the best emergency treatment for children who ingest warfarin rodenticide? Medical Journal of Australia 174(3): 147
Bonfils, S.; Mignon, M.; Accary, J.P. 1975: Secretin provocation test in Zollinger-Ellison syndrome (Z.E.S.) with medical (metiamide) and/or surgical treatment Acta Hepato-Gastroenterologica 22(1): 60
Naidoo, K.; Baxter, C.; Abdool Karim, S.S. 2013: When to start antiretroviral therapy during tuberculosis treatment? Current Opinion in Infectious Diseases 26(1): 35-42
Vernotico, V.; Zanella, B.; Mari, A. 1989: Danazol in the treatment of menometrorrhagia in patients with mitral prosthesis treated with warfarin Minerva Ginecologica 41(6): 291-293
Van Leeuwen, G.; Blanton, J.; Fogarty, R. 1969: Developing health services for a rural Head Start Program. Problems encountered in establishi a community head start health service for small children Clinical Pediatrics 8(9): 531-536
Gulløv, A.L.; Koefoed, B.G.; Petersen, P.; Pedersen, T.S.; Andersen, E.D.; Godtfredsen, J.; Boysen, G. 1998: Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study Archives of Internal Medicine 158(14): 1513-1521
Stefan, C.; Ene, L.; Coravu, C.O. 2014: When and how we start the treatment in patients with ocular hypertension or in glaucoma suspects? Oftalmologia 58(1): 15-17
Myllykangas-Luosujärvi, R. 1998: Start treatment of temporalis arteritis immediately--otherwise your patient might become blind! Duodecim; Laaketieteellinen Aikakauskirja 114(21): 2183-2185
Schori, T.R.; Stungis, G.E. 2004: Long-term warfarin treatment may induce arterial calcification in humans: case report Clinical and Investigative Medicine 27(2): 107-109
Varim, P.; Varim, C.; Ergenç, H.; Uyanık, M.; Yaylacı, S.; Vatan, M.; Gündüz, H. 2016: Assessment of Warfarin Treatment Efficacy by Means; of using Coagulation test Results within the Therapeutic Range Georgian Medical News 255: 62-66
Liakishev, A.A. 2010: Dabigatran versus warfarin in the treatment of acute venous thromboembolism. Results of the RE-COVER study Kardiologiia 50(3): 80-81
Libânio, P.A.C.; Costa, B.M.P.; Cintra, I.S.; Chernicharo, C.A.L. 2003: Evaluation of the start-up of an integrated municipal solid waste and leachate treatment system Water Science and Technology: a Journal of the International Association on Water Pollution Research 48(6): 241-247
Geffen, N.; Aagaard, P.; Corbelli, G.M.; Meulbroek, M.; Peavy, D.; Rappoport, C.; Schwarze, S.; Collins, S. 2015: Community perspective on the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial HIV Medicine 16(Suppl 1): 10-13